EGFR and ovarian carcinoma: In conclusion, in these initial experiments we show that malignant ascites derived from patients with ovarian carcinoma or other adenocarcinoma but not benign ascites causes substantial suppression of major antitumoral NK cell effector functions during interaction with various EGFR-positive target cells.